Dalton Receives Compliant Rating From Health Canada
News May 27, 2016
Dalton Pharma Services, a leading Contract Development and Manufacturing Organization, is proud to announce that it has successfully completed another Health Canada inspection and has received a compliant rating from the Health Products and Food Branch Inspectorate of Health Canada.
The inspection covered the scope of sterile and non-sterile drug products, Active Pharmaceutical Ingredients (API) and laboratory operations, and included clinical products. The compliant rating means that the company has successfully demonstrated these activities are in compliance with the high standards of the Canadian Food and Drugs Act and its associated regulations.
“The successful completion of our Health Canada inspection is the direct result of the hard work and dedication of everyone at Dalton as well as our ongoing commitment to providing the highest quality standards to our clients,” said Peter Pekos, President and CEO.
“I believe this compliant inspection is a direct result of having ingrained GMP and compliance into our core company values. The positive result of this inspection will allow Dalton to improve upon our processes as we strive to consistently provide the highest quality for our clients.” said Karina Lahnakoski, Director of Quality.
As a result of achieving the compliant rating, Dalton will continue to provide manufacturing, filling, packaging and testing services to the pharmaceutical and biotechnology industries. Dalton continues to build an impressive regulatory track record, having now completed 6 successful Health Canada inspections, and will continue to uphold the highest quality standards while serving its clients.
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE